Fol. Biol. 2012, 58, 75-80
https://doi.org/10.14712/fb2012058020075
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Non-small Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation
References
1. , J., Kudláč, M., Žák, V., Čavarga, I., Kočan, P., Böör, A., Stebnický, M., Somoš, A., Tkáčová, R. (2010) Surgical management of bronchopulmonary carcinoid tumors: experience over 8 years and review of the literature. Tumori 96, 84-89.
<https://doi.org/10.1177/030089161009600114>
2. , E. V., Boichot, E., Germain, N., Allain, N., Anger, J. P., Lagente, V. (1997) Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 330, 231-240.
<https://doi.org/10.1016/S0014-2999(97)01007-8>
3. , M., Laezza, C., Pisanti, S., Gazzerro, P. (2006) Cannabinoids and cancer: pros and cons of an antitumour strategy. Br. J. Pharmacol. 148, 123-135.
<https://doi.org/10.1038/sj.bjp.0706632>
4. , C., Casanova, M. L., Planas, A., Gomez Del Pulgar, T., Villanueva, C., Fernandez-Aceñero, M. J., Aragones, J., Huffman, J. W., Jorcano, J. L., Guzman, M. (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529-531.
<https://doi.org/10.1096/fj.02-0795fje>
5. , C., Gonzalez-Feria, L., Alvarez, L., Haro, A., Casanova, M. L., Guzman, M. (2004) Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 64, 5617-5623.
<https://doi.org/10.1158/0008-5472.CAN-03-3927>
6. , C., Salazar, M., Carracedo, A., Lorente, M., Egia, A., Gonzalez-Feria, L., Haro, A., Velasco, G., Guzman, M. (2008) Cannabinoids inhibit glioma cell invasion by downregulating matrix metalloproteinase-2 expression. Cancer Res. 68, 1945-1952.
<https://doi.org/10.1158/0008-5472.CAN-07-5176>
7. , K. J. Jr., Li, G. (2002) The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells. Int. J. Oncol. 21, 1361-1365.
8. , P., van Hinsbergh, V. W. M., Bertolotto, A., Rossino, P., Silengo, L., Tarone, G. (1991) Differential distribution and modulation of expression of α1/β1 integrin on human endothelial cells. J. Cell Biol. 114, 855-863.
<https://doi.org/10.1083/jcb.114.4.855>
9. , N., Kerbel, R. S. (2005) Angiogenesis as a therapeutic target. Nature 438, 967-974.
<https://doi.org/10.1038/nature04483>
10. , M. A. (1977) In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas. Cancer Biochem. Biophys. 2, 51-54.
11. , F. (2005) Cannabinoids. Curr. Drug Targets CNS Neurol. Disord. 4, 507-530.
<https://doi.org/10.2174/156800705774322111>
12. , V. W. M., Sprengers, E. D., Kooistra, E. A. (1987) Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb. Haemost. 57, 148-153.
13. , D., Procházková, J., Kubala, L., Pacherník, J. (2009) Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-α. Gen. Physiol. Biophys. 28, 294-301.
<https://doi.org/10.4149/gpb_2009_03_294>
14. , B., Quesada, A. R., Medina, M. A. (2005) Hypericin in the dark inhibits key steps of angiogenesis in vitro. Eur. J. Pharmacol. 516, 97-103.
<https://doi.org/10.1016/j.ejphar.2005.03.047>
15. , L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
<https://doi.org/10.1038/346561a0>
16. , T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 65, 55-63.
<https://doi.org/10.1016/0022-1759(83)90303-4>
17. , S., Thomas, K. L., Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
<https://doi.org/10.1038/365061a0>
18. , A. E., Harris, L. S., Friedman, M. A. (1975) Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst. 55, 597-602.
<https://doi.org/10.1093/jnci/55.3.597>
19. , E. W., Ali, M. A., Schnee, T., Lan, L., Lukyanov, Y., Fowkes, M., Miller, D. C., Zagzag, D. (2005) Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy. Neuro. Oncol. 7, 225-235.
<https://doi.org/10.1215/S1152851704000997>
20. , D., Saczko, J., Kulbacka, J., Choromanska, A. (2010) Dynamic oxidoreductive potential of astringent retraction agents. Folia Biol. (Praha) 56, 263-268.
21. , A., Qamri, Z., Nasser, M. W., Prasad, A., Shilo, K., Zou, X., Groopman, J. E., Ganju, R. K. (2011) Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev. Res. (Phila) 4, 65-75.
<https://doi.org/10.1158/1940-6207.CAPR-10-0181>
22. de Fonseca, F., Del Arco, I., Bermudez-Silva, F. J., Bilbao, A., Cippitelli, A., Navarro, M. (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol. 40, 2-14.
<https://doi.org/10.1093/alcalc/agh110>
23. , S., Adhami, V. M., Syed, D. N., Afaq, F., Mukhtar, H (2008) Cannabinoids for cancer treatment: progress and promise. Cancer Res. 68, 339-342.
<https://doi.org/10.1158/0008-5472.CAN-07-2785>
24. , M., Ständer, S., Kerner, J., Vajkoczy, P., Schüpfer, G., Dusch, M., Schmelz, M., Konrad, C. (2009) Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Res. Bull. 79, 333-337.
<https://doi.org/10.1016/j.brainresbull.2009.01.011>
25. , B., Gál, P., Mojžiš, J. (2006) Different views on the association between cannabinoids and cancer. Čas. Lek. Čes. 145, 453-457. (in Slovak)
26. , A. C., Munson, J. A., Munson, A. E., Carchman, R. A. (1976) Effects of Δ9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture. J. Natl. Cancer Inst. 56, 655-658.
<https://doi.org/10.1093/jnci/56.3.655>
